The possibility of interfering with this detrimental cycle by pharmacologically inhibiting RAGE expression and reactive gliosis has been proposed as one of the targets for developing drugs to reduce neuronal damage and consequently slow the progress of AD. Here, AGER is linked to Alzheimer disease.